KCTD20
BTB/POZ domain-containing protein KCTD20
Also known as: C6orf69, dJ108K11.3, KCD20_HUMAN, MGC14254
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z5Y7
- Gene
- KCTD20
- Ensembl
- ENSG00000112078
- Chromosome
- 6
- Canonical length
- 419 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Endoplasmic reticulum
OverviewNCBI Gene
Predicted to enable identical protein binding activity. Predicted to be involved in positive regulation of phosphorylation. Predicted to be located in membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
419 residues, UniProt reviewed canonical sequence.
>Q7Z5Y7|KCTD20
1 MNVHRGSDSD RLLRQEASCL VDDTLAVAQE KEANSLASSG PHNLTYPLGP RNEDLSLDYA
61 SQPANLQFPH IMPLAEDIKG SCFQSGNKRN HEPFIAPERF GNSSVGFGSN SHSQAPEKVT
121 LLVDGTRFVV NPQIFTAHPD TMLGRMFGPG REYNFTRPNE KGEYEIAEGI SATVFRTVLD
181 YYKTGIINCP DGISIPDLRD TCDYLCINFD FNTIRCQDLS ALLHELSNDG AHKQFDHYLE
241 ELILPIMVGC AKKGERECHI VVLTDEDSVD WDEDHPPPMG EEYSQILYSS KLYRFFKYIE
301 NRDVAKTVLK ERGLKNIRIG IEGYPTCKEK IKRRPGGRSE VIYNYVQRPF IQMSWEKEEG
361 KSRHVDFQCV RSKSLTNLVA AGDDVLEDQE ILMHHPPQVD ELDRLNAPLS QMASNDFQDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCTD20 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 39 nTPM
- thymus: 32 nTPM
- smooth muscle: 30 nTPM
- liver: 29 nTPM
- skin: 28 nTPM
- tonsil: 28 nTPM
Single-cell type
- platelets: 540 nCPM
- neutrophils: 376 nCPM
- monocytes: 256 nCPM
- esophageal apical cells: 196 nCPM
- mast cells: 126 nCPM
- cdc: 126 nCPM
Immune cell
- basophil: 30 nTPM
- classical monocyte: 17 nTPM
- myeloid DC: 16 nTPM
- intermediate monocyte: 15 nTPM
- total PBMC: 14 nTPM
- neutrophil: 13 nTPM
Brain region
- hypothalamus: 41 nTPM
- midbrain: 40 nTPM
- medulla oblongata: 39 nTPM
- pons: 39 nTPM
- thalamus: 36 nTPM
- white matter: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCTD20 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCTD20 as an antibody target. Whether an autoantibody or antibody against KCTD20 could matter depends on whether native KCTD20 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCTD20 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KCTD20 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...